<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Fanconi Anemia Hub | CarePedia Information Center</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Rubik:wght@300;400;500;600;700;800;900&display=swap" rel="stylesheet">
<link rel="alternate" hreflang="he" href="https://carepedia.org/fanconi-anemia" />
<link rel="alternate" hreflang="en" href="https://carepedia.org/en/fanconi-anemia" />

<style>
* { margin: 0; padding: 0; box-sizing: border-box; }

:root {
  --primary: #0f4c75;
  --primary-light: #3282b8;
  --accent: #00b894;
  --accent-light: #55efc4;
  --warm: #fdcb6e;
  --warm-dark: #e17055;
  --bg: #f0f4f8;
  --card: #ffffff;
  --text: #2c3e50;
  --text-light: #5d6d7e;
  --shadow: 0 4px 20px rgba(0,0,0,0.08);
  --shadow-hover: 0 12px 40px rgba(0,0,0,0.18);
  --radius: 16px;
  --transition: all 0.3s cubic-bezier(.4,0,.2,1);
  /* Aliases for Iconify icons */
  --forest: #0f4c75;
  --forest-mid: #3282b8;
  --forest-light: rgba(50,130,184,0.12);
  --amber: #fdcb6e;
  --amber-light: rgba(253,203,110,0.12);
  --border: #dde4eb;
}

body {
  font-family: 'Rubik', 'Segoe UI', Tahoma, Arial, sans-serif;
  background: var(--bg);
  color: var(--text);
  line-height: 1.8;
  overflow-x: hidden;
  position: relative;
}

body::before {
  content: '';
  position: fixed;
  top: 0; left: 0; width: 100vw; height: 100vh;
  background:
    radial-gradient(ellipse at 10% 20%, rgba(15,76,117,0.07) 0%, transparent 50%),
    radial-gradient(ellipse at 90% 80%, rgba(0,184,148,0.07) 0%, transparent 50%),
    radial-gradient(ellipse at 50% 50%, rgba(253,203,110,0.05) 0%, transparent 60%);
  pointer-events: none;
  z-index: 0;
}

.scroll-progress {
  position: fixed;
  top: 0; right: 0;
  width: 100%; height: 4px;
  z-index: 2000;
  background: transparent;
}
.scroll-progress .bar {
  height: 100%; width: 0%;
  background: linear-gradient(90deg, var(--accent), var(--primary-light), var(--warm));
  border-radius: 0 0 0 4px;
  transition: width 0.1s linear;
}

.sidebar {
  position: fixed;
  top: 0; left: 0;
  width: 280px; height: 100vh;
  background: rgba(15,76,117,0.85);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border-right: 1px solid rgba(255,255,255,0.1);
  z-index: 1000;
  padding: 30px 20px;
  overflow-y: auto;
  transition: transform 0.4s cubic-bezier(.4,0,.2,1);
}
.sidebar .logo {
  text-align: center;
  margin-bottom: 30px;
  padding-bottom: 20px;
  border-bottom: 1px solid rgba(255,255,255,0.15);
}
.sidebar .logo .icon { font-size: 48px; }
.sidebar .logo h2 { color: #fff; font-size: 18px; margin-top: 8px; font-weight: 600; }
.sidebar nav a {
  display: flex; align-items: center; gap: 12px;
  padding: 14px 18px; color: rgba(255,255,255,0.8);
  text-decoration: none; border-radius: 12px;
  margin-bottom: 4px; font-size: 15px; transition: var(--transition);
}
.sidebar nav a:hover, .sidebar nav a.active {
  background: rgba(255,255,255,0.15); color: #fff; transform: translateX(4px);
}
.sidebar nav a .nav-icon { font-size: 22px; min-width: 30px; text-align: center; }

.menu-toggle {
  display: none;
  position: fixed;
  top: 20px; left: 20px;
  z-index: 1100;
  background: var(--primary); color: #fff;
  border: none; border-radius: 12px;
  width: 50px; height: 50px; font-size: 24px;
  cursor: pointer; box-shadow: var(--shadow); transition: var(--transition);
}
.menu-toggle:hover { transform: scale(1.05); }
.menu-toggle.open { border-radius: 50%; background: var(--warm-dark); }

.main {
  margin-left: 280px;
  min-height: 100vh;
  position: relative;
  z-index: 1;
}

.hero {
  background: linear-gradient(135deg, var(--primary) 0%, #3282b8 40%, var(--accent) 100%);
  padding: 80px 60px;
  color: #fff;
  position: relative;
  overflow: hidden;
}
.hero::before {
  content: '';
  position: absolute;
  top: -50%; left: -50%;
  width: 200%; height: 200%;
  background: radial-gradient(circle, rgba(255,255,255,0.05) 0%, transparent 60%);
  animation: float 20s linear infinite;
}
@keyframes float { 0% { transform: rotate(0deg); } 100% { transform: rotate(360deg); } }
.hero-content { position: relative; z-index: 1; max-width: 900px; }
.hero h1 { font-size: 52px; font-weight: 800; margin-bottom: 10px; line-height: 1.3; }
.hero .greeting { font-size: 22px; opacity: 0.95; margin-bottom: 30px; line-height: 1.7; }
.hero .subtitle { font-size: 18px; opacity: 0.8; max-width: 700px; }

.fade-in { opacity: 0; transform: translateY(30px); transition: opacity 0.7s ease, transform 0.7s ease; }
.fade-in.visible { opacity: 1; transform: translateY(0); }

.section { padding: 60px; max-width: 1100px; margin: 0 auto; }
.section-header {
  display: flex; align-items: center; gap: 16px;
  margin-bottom: 40px; padding-bottom: 20px;
  border-bottom: 3px solid var(--primary-light);
}
.section-header .sec-icon { font-size: 42px; }
.section-header h2 { font-size: 36px; color: var(--primary); }
.section-header p { color: var(--text-light); font-size: 16px; margin-top: 4px; }

.cards-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
  gap: 24px; margin-bottom: 40px;
}
.card {
  background: var(--card); border-radius: var(--radius); padding: 30px;
  box-shadow: var(--shadow); transition: var(--transition);
  border-top: 4px solid var(--primary-light);
  position: relative; overflow: hidden;
}
.card:hover { transform: translateY(-6px) scale(1.01); box-shadow: var(--shadow-hover); }
.card .card-icon { font-size: 40px; margin-bottom: 16px; }
.card h3 { font-size: 20px; color: var(--primary); margin-bottom: 12px; }
.card p { color: var(--text-light); font-size: 15px; line-height: 1.8; }
.card.green { border-top-color: var(--accent); }
.card.orange { border-top-color: var(--warm); }
.card.blue { border-top-color: var(--primary-light); }

.cat-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(240px, 1fr));
  gap: 20px; margin-top: 40px;
}
.cat-card {
  background: var(--card); border-radius: var(--radius); padding: 30px 24px;
  text-align: center; cursor: pointer; transition: var(--transition);
  box-shadow: var(--shadow); text-decoration: none; color: var(--text);
}
.cat-card:hover { transform: translateY(-6px) scale(1.02); box-shadow: var(--shadow-hover); }
.cat-card .cat-icon { font-size: 48px; margin-bottom: 14px; }
.cat-card h3 { font-size: 18px; color: var(--primary); margin-bottom: 8px; }
.cat-card p { font-size: 13px; color: var(--text-light); }

.accordion { margin-bottom: 16px; }
.accordion-header {
  background: var(--card); padding: 20px 24px; border-radius: var(--radius);
  cursor: pointer; display: flex; justify-content: space-between; align-items: center;
  box-shadow: var(--shadow); transition: var(--transition);
  font-size: 17px; font-weight: 600; color: var(--primary);
}
.accordion-header:hover { background: #eef4fb; }
.accordion-header .arrow { transition: transform 0.3s ease; font-size: 20px; }
.accordion-header.open .arrow { transform: rotate(180deg); }
.accordion-body {
  max-height: 0; overflow: clip; transition: max-height 0.4s ease;
  background: var(--card); border-radius: 0 0 var(--radius) var(--radius); margin-top: -8px;
}
.accordion-body .inner { padding: 20px 24px 24px; color: var(--text-light); line-height: 2; }

.tabs { display: flex; gap: 8px; margin-bottom: 24px; flex-wrap: wrap; }
.tab-btn {
  padding: 12px 24px; background: var(--card);
  border: 2px solid #dde4eb; border-radius: 30px;
  cursor: pointer; font-size: 15px; font-family: inherit;
  color: var(--text-light); transition: var(--transition);
}
.tab-btn:hover { border-color: var(--primary-light); color: var(--primary); }
.tab-btn.active { background: var(--primary); color: #fff; border-color: var(--primary); }
.tab-content { display: none; animation: fadeIn 0.4s ease; }
.tab-content.active { display: block; }
@keyframes fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }

.info-box {
  background: linear-gradient(135deg, #eaf4fb 0%, #e8f8f0 100%);
  border-radius: var(--radius); padding: 24px 28px; margin: 24px 0;
  border-left: 5px solid var(--primary-light);
}
.info-box.warning { background: linear-gradient(135deg, #fef9e7 0%, #fdebd0 100%); border-left-color: var(--warm); }
.info-box.success { background: linear-gradient(135deg, #e8f8f0 0%, #d5f5e3 100%); border-left-color: var(--accent); }
.info-box h4 { color: var(--primary); margin-bottom: 8px; font-size: 17px; }
.info-box p { color: var(--text-light); font-size: 15px; }

.link-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 12px 24px; background: var(--primary);
  color: #fff; text-decoration: none; border-radius: 30px;
  font-size: 15px; transition: var(--transition); margin: 6px;
}
.link-btn:hover { background: var(--primary-light); transform: translateY(-2px); }
.link-btn.green { background: var(--accent); }
.link-btn.green:hover { background: var(--accent-light); color: var(--text); }
.link-btn.orange { background: var(--warm-dark); }
.link-btn.orange:hover { background: var(--warm); color: var(--text); }

.styled-table {
  width: 100%; border-collapse: collapse; margin: 20px 0;
  background: var(--card); border-radius: var(--radius);
  overflow: hidden; box-shadow: var(--shadow);
}
.styled-table thead { background: var(--primary); color: #fff; }
.styled-table th { padding: 16px 20px; text-align: left; font-weight: 600; }
.styled-table td { padding: 14px 20px; border-bottom: 1px solid #eee; }
.styled-table tbody tr:hover { background: #f7fafc; }

.timeline { position: relative; padding-left: 40px; margin: 30px 0; }
.timeline::before {
  content: '';
  position: absolute; left: 12px; top: 0; bottom: 0;
  width: 3px;
  background: linear-gradient(to bottom, var(--primary-light), var(--accent));
  border-radius: 3px;
}
.timeline-item {
  position: relative; margin-bottom: 30px; padding: 24px;
  background: var(--card); border-radius: var(--radius); box-shadow: var(--shadow);
}
.timeline-item::before {
  content: ''; position: absolute;
  left: -34px; top: 30px;
  width: 16px; height: 16px;
  background: var(--accent); border-radius: 50%; border: 3px solid var(--bg);
}
.timeline-item h4 { color: var(--primary); font-size: 18px; margin-bottom: 8px; }
.timeline-item p { color: var(--text-light); }
.timeline-item .time-label {
  display: inline-block; background: var(--primary); color: #fff;
  padding: 4px 14px; border-radius: 20px; font-size: 13px; margin-bottom: 10px;
}

.stats-row {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(200px, 1fr));
  gap: 20px; margin: 30px 0;
}
.stat-box {
  background: linear-gradient(135deg, var(--card) 0%, #f7fafc 100%);
  border-radius: var(--radius); padding: 24px; text-align: center;
  box-shadow: var(--shadow); border-bottom: 3px solid var(--primary-light);
  transition: var(--transition);
}
.stat-box:nth-child(2) { border-bottom-color: var(--accent); }
.stat-box:nth-child(3) { border-bottom-color: var(--warm); }
.stat-box:nth-child(4) { border-bottom-color: var(--warm-dark); }
.stat-box:hover { transform: translateY(-4px); box-shadow: var(--shadow-hover); }
.stat-box .stat-num {
  font-size: 36px; font-weight: 800;
  background: linear-gradient(135deg, var(--primary), var(--accent));
  -webkit-background-clip: text; -webkit-text-fill-color: transparent; background-clip: text;
}
.stat-box .stat-label { color: var(--text-light); font-size: 14px; margin-top: 6px; }

.carepedia-cta {
  background: linear-gradient(135deg, #1A73E8, #00C9A7);
  padding: 48px 24px; text-align: center; color: #fff;
}
.carepedia-cta h3 { font-size: 24px; font-weight: 700; margin-bottom: 12px; }
.carepedia-cta p { font-size: 16px; opacity: 0.9; margin-bottom: 24px; max-width: 500px; margin-left: auto; margin-right: auto; }
.carepedia-cta .cta-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 14px 32px; background: #fff; color: #1A73E8;
  text-decoration: none; border-radius: 30px; font-size: 16px; font-weight: 700;
  font-family: inherit; transition: all 0.3s ease; box-shadow: 0 4px 16px rgba(0,0,0,0.15);
}
.carepedia-cta .cta-btn:hover { transform: translateY(-2px); box-shadow: 0 8px 24px rgba(0,0,0,0.2); }

.credit-bar {
  display: flex; align-items: center; justify-content: center; gap: 16px; flex-wrap: wrap;
  padding: 14px 20px; font-size: 14px; color: rgba(255,255,255,0.85); position: relative; z-index: 1;
}
.credit-bar span { opacity: 0.9; }
.portal-request-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 10px 22px; background: var(--primary-light); color: #fff;
  text-decoration: none; border-radius: 30px; font-size: 14px;
  font-family: inherit; font-weight: 600; transition: var(--transition);
  box-shadow: 0 2px 12px rgba(0,0,0,0.15);
}
.portal-request-btn:hover { background: var(--primary); transform: translateY(-2px); box-shadow: 0 4px 20px rgba(0,0,0,0.2); }

.footer {
  background: var(--primary); color: rgba(255,255,255,0.8);
  text-align: center; padding: 40px; font-size: 14px;
}

.scroll-top {
  position: fixed; bottom: 30px; left: 30px;
  width: 50px; height: 50px; background: var(--primary);
  color: #fff; border: none; border-radius: 50%;
  font-size: 22px; cursor: pointer; box-shadow: var(--shadow);
  transition: var(--transition); opacity: 0; pointer-events: none; z-index: 999;
}
.scroll-top.visible { opacity: 1; pointer-events: auto; }
.scroll-top:hover { background: var(--primary-light); transform: translateY(-3px); }

.search-box { position: relative; margin: 0 auto; }
.search-box input {
  width: 100%; padding: 14px 20px 14px 50px;
  border: 2px solid rgba(15,76,117,0.15); border-radius: 30px;
  font-size: 16px; font-family: 'Rubik', sans-serif;
  background: var(--card); color: var(--text); transition: var(--transition);
  box-sizing: border-box;
}
.search-box input:focus { outline: none; border-color: var(--primary-light); box-shadow: 0 0 0 4px rgba(50,130,184,0.1); }
.search-box .search-icon {
  position: absolute; left: 18px; top: 50%;
  transform: translateY(-50%); font-size: 20px; pointer-events: none;
}

.sidebar-overlay {
  display: none; position: fixed; top: 0; left: 0; right: 0; bottom: 0;
  background: rgba(0,0,0,0.5); z-index: 999; opacity: 0; transition: opacity 0.3s ease;
}
.sidebar-overlay.active { display: block; opacity: 1; }

@media (max-width: 900px) {
  .sidebar { transform: translateX(-100%); width: 270px; }
  .sidebar.open { transform: translateX(0); }
  .menu-toggle { display: block; }
  .main { margin-left: 0; }
  .hero { padding: 60px 30px; }
  .section { padding: 40px 24px; }
}

@media (max-width: 768px) {
  .sidebar { transform: translateX(-100%); width: 260px; }
  .sidebar.open { transform: translateX(0); }
  .menu-toggle { display: block; }
  .main { margin-left: 0; }
  .hero { padding: 40px 20px 36px; }
  .hero h1 { font-size: 28px; line-height: 1.3; }
  .hero .greeting { font-size: 16px; line-height: 1.7; }
  .hero .subtitle { font-size: 14px; }
  .section { padding: 28px 16px; }
  .section-header { flex-direction: column; align-items: flex-start; gap: 8px; margin-bottom: 24px; padding-bottom: 14px; }
  .section-header .sec-icon { font-size: 32px; }
  .section-header h2 { font-size: 24px; }
  .section-header p { font-size: 14px; }
  .cards-grid { grid-template-columns: 1fr; gap: 16px; margin-bottom: 24px; }
  .card { padding: 20px; }
  .card:hover { transform: none; }
  .cat-card:hover { transform: none; }
  .stat-box:hover { transform: none; }
  .link-btn:hover { transform: none; }
  .portal-request-btn:hover { transform: none; }
  .scroll-top:hover { transform: none; }
  .sidebar nav a:hover { transform: none; }
  .card .card-icon { font-size: 32px; margin-bottom: 10px; }
  .card h3 { font-size: 17px; }
  .card p { font-size: 14px; }
  .cat-grid { grid-template-columns: repeat(2, 1fr); gap: 12px; margin-top: 24px; }
  .cat-card { padding: 18px 12px; }
  .cat-card .cat-icon { font-size: 32px; margin-bottom: 8px; }
  .cat-card h3 { font-size: 14px; }
  .cat-card p { font-size: 11px; }
  .stats-row { grid-template-columns: repeat(2, 1fr); gap: 12px; margin: 20px 0; }
  .stat-box { padding: 16px 10px; }
  .stat-box .stat-num { font-size: 26px; }
  .stat-box .stat-label { font-size: 12px; }
  .tabs { gap: 6px; margin-bottom: 16px; }
  .tab-btn { padding: 8px 14px; font-size: 13px; border-radius: 20px; }
  .styled-table { display: block; overflow-x: auto; -webkit-overflow-scrolling: touch; font-size: 13px; }
  .styled-table th { padding: 10px 12px; font-size: 13px; white-space: nowrap; }
  .styled-table td { padding: 10px 12px; font-size: 13px; min-width: 100px; }
  .info-box { padding: 16px 18px; margin: 16px 0; }
  .info-box h4 { font-size: 15px; }
  .info-box p { font-size: 13px; }
  .accordion-header { padding: 14px 16px; font-size: 15px; }
  .accordion-body .inner { padding: 14px 16px 18px; font-size: 14px; line-height: 1.9; }
  .timeline { padding-left: 30px; margin: 20px 0; }
  .timeline-item { padding: 16px; margin-bottom: 20px; }
  .timeline-item::before { left: -24px; width: 12px; height: 12px; top: 22px; }
  .timeline-item h4 { font-size: 16px; }
  .timeline-item p { font-size: 13px; }
  .link-btn { padding: 10px 16px; font-size: 13px; margin: 4px 2px; }
  .search-box input { padding: 12px 18px 12px 40px; font-size: 14px; }
  .footer { padding: 28px 16px; font-size: 13px; }
  .scroll-top { width: 42px; height: 42px; font-size: 18px; bottom: 20px; left: 16px; }
}

@media (max-width: 380px) {
  .hero h1 { font-size: 24px; }
  .hero .greeting { font-size: 15px; }
  .cat-grid { grid-template-columns: 1fr 1fr; gap: 8px; }
  .cat-card { padding: 14px 8px; }
  .cat-card .cat-icon { font-size: 26px; }
  .cat-card h3 { font-size: 13px; }
  .cat-card p { display: none; }
  .stats-row { grid-template-columns: 1fr 1fr; gap: 8px; }
  .stat-box .stat-num { font-size: 22px; }
  .section { padding: 20px 12px; }
  .tab-btn { padding: 7px 10px; font-size: 12px; }
}

.disclaimer-banner {
  background: linear-gradient(135deg, #FFF3E0, #FFF8E1);
  border-bottom: 2px solid #FFB74D;
  padding: 10px 20px; text-align: center; font-size: 13px; color: #5D4037;
  position: relative; z-index: 1500;
  display: flex; align-items: center; justify-content: center; gap: 8px; flex-wrap: wrap;
}
.disclaimer-banner strong { color: #E65100; }
.disclaimer-banner a { color: #1A73E8; text-decoration: underline; font-weight: 600; }
.disclaimer-banner a:hover { color: #0D47A1; }
@media (max-width: 768px) { .disclaimer-banner { font-size: 12px; padding: 8px 12px; } }
</style>
<script src="https://code.iconify.design/iconify-icon/2.1.0/iconify-icon.min.js" defer></script>
</head>
<body>
<div class="scroll-progress"><div class="bar"></div></div>
<div class="disclaimer-banner">
  ‚öïÔ∏è <strong>Medical Disclaimer:</strong> This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional. <a href="#resources">Find specialists &rarr;</a>
</div>
<button class="menu-toggle" onclick="toggleMenu()">&#9776;</button>
<div class="sidebar-overlay" onclick="closeMenu()"></div>

<nav class="sidebar">
  <div class="logo">
    <div class="icon">ü©∏</div>
    <h2>Fanconi Anemia<br>Information Hub</h2>
  </div>
  <div class="search-box" style="margin-bottom:16px;">
    <span class="search-icon">üîç</span>
    <input type="text" placeholder="Search the portal..." oninput="searchPortal(this.value)">
  </div>
  <nav>
    <a href="#about" onclick="navigate('about')"><span class="nav-icon">üìñ</span> About FA</a>
    <a href="#genetics" onclick="navigate('genetics')"><span class="nav-icon">üß¨</span> Genetics</a>
    <a href="#diagnosis" onclick="navigate('diagnosis')"><span class="nav-icon">üî¨</span> Diagnosis</a>
    <a href="#complications" onclick="navigate('complications')"><span class="nav-icon">‚ö†Ô∏è</span> Complications</a>
    <a href="#treatments" onclick="navigate('treatments')"><span class="nav-icon">üíä</span> Treatments</a>
    <a href="#trials" onclick="navigate('trials')"><span class="nav-icon">üß™</span> Clinical Trials</a>
    <a href="#surveillance" onclick="navigate('surveillance')"><span class="nav-icon">üìÖ</span> Surveillance</a>
    <a href="#psychological" onclick="navigate('psychological')"><span class="nav-icon">üß†</span> Mental Health</a>
    <a href="#resources" onclick="navigate('resources')"><span class="nav-icon">üåê</span> Resources</a>
  </nav>
  <div style="margin-top:30px; padding-top:20px; border-top:1px solid rgba(255,255,255,0.15); text-align:center;">
    <a href="/en/" class="portal-request-btn">‚Üê All Portals</a>
  </div>
</nav>

<main class="main">
  <section class="hero">
    <div class="hero-content">
      <h1>ü©∏ Fanconi Anemia</h1>
      <p class="greeting">A rare inherited disorder affecting the body's ability to repair DNA ‚Äî causing bone marrow failure, increased cancer risk, and physical anomalies.</p>
      <p class="subtitle">Comprehensive, evidence-based information for patients, families, and healthcare providers.</p>
    </div>
    <div class="stats-row" style="margin-top:40px;">
      <div class="stat-box"><div class="stat-num">1:130,000</div><div class="stat-label">Live births affected worldwide</div></div>
      <div class="stat-box"><div class="stat-num">22+</div><div class="stat-label">FANC genes linked to FA (FANCA, FANCC, FANCG most common)</div></div>
      <div class="stat-box"><div class="stat-num">~60%</div><div class="stat-label">Develop AML or MDS by age 40 without treatment</div></div>
      <div class="stat-box"><div class="stat-num">HSCT</div><div class="stat-label">Only curative treatment for bone marrow failure</div></div>
    </div>
  </section>

  <section class="section fade-in" id="about">
    <div class="section-header">
      <span class="sec-icon">üìñ</span>
      <div><h2>What Is Fanconi Anemia?</h2>
      <p>A rare inherited DNA repair disorder with complex systemic effects</p></div>
    </div>
    <div class="info-box success">
      <h4>Fanconi anemia is a DNA repair disorder, not only a blood disease</h4>
      <p>FA is caused by mutations in genes that form the Fanconi anemia DNA repair pathway. When this pathway fails, damaged DNA cannot be repaired, leading to chromosomal instability. This causes: progressive bone marrow failure (aplastic anemia), dramatically increased cancer risk (especially AML and squamous cell carcinoma), and developmental physical anomalies in many patients.</p>
    </div>
    <div class="cards-grid">
      <div class="card green">
        <div class="card-icon">üß¨</div>
        <h3>Inheritance Pattern</h3>
        <p>Most FA subtypes are autosomal recessive ‚Äî a child must inherit one mutated FANC gene from each parent. FANCB follows X-linked recessive inheritance (males predominantly affected). Carriers (one mutation) are unaffected but can pass the mutation to children.</p>
      </div>
      <div class="card orange">
        <div class="card-icon">üìä</div>
        <h3>Who Is Affected</h3>
        <p>FA affects all ethnicities but certain populations have higher carrier rates: Ashkenazi Jewish (FANCC IVS4+4A&gt;T), Afrikaner South Africans (FANCA del exon 11-17), and Spanish Roma (FANCA exon 4). Median age of diagnosis: 7 years. Symptoms of bone marrow failure typically begin in childhood.</p>
      </div>
      <div class="card blue">
        <div class="card-icon">‚ö†Ô∏è</div>
        <h3>Physical Anomalies</h3>
        <p>Approximately 60-75% of patients have at least one physical anomaly: thumb/radial ray abnormalities (most common), skin caf√©-au-lait spots, short stature, kidney malformations, hearing loss, microcephaly, eye abnormalities, or hypogonadism. About 25-40% have no physical anomalies.</p>
      </div>
    </div>
  </section>

  <section class="section fade-in" id="genetics">
    <div class="section-header">
      <span class="sec-icon">üß¨</span>
      <div><h2>Genetics of Fanconi Anemia</h2>
      <p>22+ FANC genes and the DNA repair pathway</p></div>
    </div>
    <table class="styled-table">
      <thead><tr><th>Gene</th><th>% of FA Cases</th><th>Notes</th></tr></thead>
      <tbody>
        <tr><td><strong>FANCA</strong></td><td>~60-65%</td><td>Most common; multiple ethnic-specific founder mutations</td></tr>
        <tr><td><strong>FANCC</strong></td><td>~10-15%</td><td>Common in Ashkenazi Jewish population</td></tr>
        <tr><td><strong>FANCG</strong></td><td>~10%</td><td>Often associated with more severe disease</td></tr>
        <tr><td><strong>FANCD2</strong></td><td>~3-4%</td><td>Core pathway protein; more severe phenotype</td></tr>
        <tr><td><strong>BRCA2 (FANCD1)</strong></td><td>~2%</td><td>Associated with early-onset solid tumors (medulloblastoma, Wilms tumor)</td></tr>
        <tr><td><strong>FANCB</strong></td><td>Very rare</td><td>X-linked; most severe form, often early lethal</td></tr>
        <tr><td><strong>All others</strong></td><td>~5-10%</td><td>FANCE, FANCF, FANCI, FANCJ, FANCL, FANCM, FANCN, FANCO, FANCP, FANCQ, FANCR, FANCS, FANCT, FANCU, FANCV, FANCW</td></tr>
      </tbody>
    </table>
  </section>

  <section class="section fade-in" id="diagnosis">
    <div class="section-header">
      <span class="sec-icon">üî¨</span>
      <div><h2>Diagnosis</h2>
      <p>Chromosome breakage testing is the gold standard</p></div>
    </div>
    <div class="cards-grid">
      <div class="card green">
        <div class="card-icon">üî¨</div>
        <h3>Chromosome Breakage Test</h3>
        <p>The gold standard diagnostic test: blood lymphocytes are exposed to crosslinking agents (DEB ‚Äî diepoxybutane, or MMC ‚Äî mitomycin C). FA cells show dramatically increased chromosomal breakage and radial figure formation. A positive DEB/MMC test is diagnostic. Skin fibroblasts can be used if blood mosaicism is suspected.</p>
      </div>
      <div class="card orange">
        <div class="card-icon">üß¨</div>
        <h3>Genetic Testing</h3>
        <p>After positive chromosome breakage test, gene sequencing (multigene FA panel) identifies the specific gene mutation. This determines FA subtype (complementation group), guides cancer surveillance protocols, and is essential for donor selection in HSCT. Prenatal diagnosis is possible once the family mutation is known.</p>
      </div>
      <div class="card blue">
        <div class="card-icon">‚öóÔ∏è</div>
        <h3>Somatic Mosaicism</h3>
        <p>~10-25% of FA patients have somatic mosaicism ‚Äî spontaneous reversion of the mutation in some blood cells. These patients may have falsely normal DEB test from blood. If mosaicism is suspected, testing fibroblasts from skin biopsy is required. Mosaicism can be protective for bone marrow failure but does not protect against solid tumors.</p>
      </div>
    </div>
  </section>

  <section class="section fade-in" id="complications">
    <div class="section-header">
      <span class="sec-icon">‚ö†Ô∏è</span>
      <div><h2>Complications</h2>
      <p>Bone marrow failure, leukemia, and solid tumor risk</p></div>
    </div>
    <div class="stats-row">
      <div class="stat-box"><div class="stat-num">90%</div><div class="stat-label">Develop bone marrow failure by age 40</div></div>
      <div class="stat-box"><div class="stat-num">~33%</div><div class="stat-label">Develop AML or MDS</div></div>
      <div class="stat-box"><div class="stat-num">700√ó</div><div class="stat-label">Increased risk of squamous cell carcinoma (head/neck, esophagus)</div></div>
    </div>
    <div class="cards-grid">
      <div class="card orange">
        <div class="card-icon">ü©∏</div>
        <h3>Bone Marrow Failure</h3>
        <p>Progressive pancytopenia (low red cells, white cells, platelets) is the most immediate life threat. Typical onset: first decade of life. Signs include fatigue, recurrent infections, easy bruising, petechiae. Regular CBC monitoring is essential from diagnosis.</p>
      </div>
      <div class="card green">
        <div class="card-icon">ü¶†</div>
        <h3>Leukemia (AML/MDS)</h3>
        <p>FA patients have dramatically increased risk of acute myeloid leukemia and myelodysplastic syndrome. These often arise from the FA bone marrow failure clone. HSCT cures bone marrow failure and largely prevents AML/MDS ‚Äî it is why timely transplant is critical.</p>
      </div>
      <div class="card blue">
        <div class="card-icon">üéóÔ∏è</div>
        <h3>Solid Tumors</h3>
        <p>Post-HSCT, FA patients face extremely high risk of squamous cell carcinoma (SCC) ‚Äî particularly of the head, neck, esophagus, and anogenital region. Risk increases with age. HPV vaccination, alcohol and tobacco avoidance, and annual surveillance are essential. Radiation therapy dramatically increases SCC risk in FA patients.</p>
      </div>
    </div>
  </section>

  <section class="section fade-in" id="treatments">
    <div class="section-header">
      <span class="sec-icon">üíä</span>
      <div><h2>Treatments</h2>
      <p>Hematopoietic stem cell transplant, androgens, and emerging gene therapy</p></div>
    </div>
    <div class="info-box success">
      <h4>HSCT (bone marrow transplant) is the only cure for bone marrow failure in FA</h4>
      <p>Hematopoietic stem cell transplant replaces the failing bone marrow with healthy donor stem cells. FA-specific reduced-intensity conditioning regimens are essential ‚Äî standard high-dose conditioning used in other transplants is toxic to FA patients due to their DNA repair defect. Best outcomes: matched sibling donor, pre-bone marrow failure, young age.</p>
    </div>
    <div class="cards-grid">
      <div class="card green">
        <div class="card-icon">üè•</div>
        <h3>HSCT ‚Äî Bone Marrow Transplant</h3>
        <p>FA-specific conditioning protocols use fludarabine-based regimens at reduced doses. Matched sibling donor = best outcomes (~90% overall survival). Matched unrelated donor outcomes have improved significantly with modern protocols. Cord blood and haploidentical (half-matched) transplants are options when MSD is unavailable.</p>
      </div>
      <div class="card orange">
        <div class="card-icon">üíä</div>
        <h3>Androgen Therapy</h3>
        <p>Oxymetholone or other androgens temporarily improve blood counts in ~50-70% of patients, delaying the need for HSCT. They are not curative and have side effects (liver toxicity, virilization, stunted growth). Useful as a bridge to transplant or when transplant is not immediately possible.</p>
      </div>
      <div class="card blue">
        <div class="card-icon">üß¨</div>
        <h3>Gene Therapy (Emerging)</h3>
        <p>Gene therapy for FANCA FA is in advanced clinical trials. The approach: correct the patient's own stem cells with a viral vector carrying a functional FANCA gene, then reinfuse ‚Äî avoiding donor-matching issues and graft-versus-host disease. Phase I/II results (FANCOLEN-I trial, Barcelona) have shown promising safety and early efficacy.</p>
        <p style="margin-top:8px; font-size:13px;"><a href="https://clinicaltrials.gov/study/NCT03157804" target="_blank" style="color:var(--accent);">FANCOLEN-I ClinicalTrials.gov</a></p>
      </div>
    </div>
  </section>

  <section class="section fade-in" id="trials">
    <div class="section-header">
      <span class="sec-icon">üß™</span>
      <div><h2>Clinical Trials</h2>
      <p>Actively recruiting and recent completed trials</p></div>
    </div>
    <div class="cards-grid">
      <div class="card green">
        <div class="card-icon">üß¨</div>
        <h3>FANCOLEN-2 (Gene Therapy)</h3>
        <p>Phase II gene therapy trial for FANCA FA. Using lentiviral vector to correct autologous hematopoietic stem cells. Building on promising FANCOLEN-1 results. <a href="https://clinicaltrials.gov/search?cond=fanconi+anemia&recrs=a" target="_blank" style="color:var(--accent);">Search ClinicalTrials.gov</a></p>
      </div>
      <div class="card orange">
        <div class="card-icon">üî¨</div>
        <h3>FANC Gene Therapy for Other Subtypes</h3>
        <p>Gene therapy trials are also in development for FANCC and FANCG subtypes. FARF (Fanconi Anemia Research Fund) coordinates international research. Registry participation helps advance research.</p>
      </div>
      <div class="card blue">
        <div class="card-icon">üè•</div>
        <h3>Transplant Protocol Studies</h3>
        <p>Ongoing studies improving HSCT outcomes in FA, particularly for mismatched donors and adult patients. Treosulfan-based conditioning is being studied as an alternative to busulfan/cyclophosphamide regimens.</p>
      </div>
    </div>
    <div style="margin-top:20px;">
      <a href="https://clinicaltrials.gov/search?cond=fanconi+anemia&recrs=a&recrs=b" target="_blank" class="link-btn">Open FA Trials</a>
      <a href="https://www.fanconi.org/research/" target="_blank" class="link-btn green">FARF Research</a>
    </div>
  </section>

  <section class="section fade-in" id="surveillance">
    <div class="section-header">
      <span class="sec-icon">üìÖ</span>
      <div><h2>Surveillance Protocol</h2>
      <p>Life-long monitoring is essential for all FA patients</p></div>
    </div>
    <table class="styled-table">
      <thead><tr><th>Screening</th><th>Frequency</th><th>Purpose</th></tr></thead>
      <tbody>
        <tr><td>Complete Blood Count (CBC)</td><td>Every 3-6 months</td><td>Monitor for bone marrow failure progression</td></tr>
        <tr><td>Bone Marrow Evaluation (biopsy + cytogenetics)</td><td>Annually or when CBC changes</td><td>Detect MDS/AML early</td></tr>
        <tr><td>Head & Neck ENT examination</td><td>Annually (more frequent post-HSCT)</td><td>Early detection of SCC</td></tr>
        <tr><td>Gynecological exam (females)</td><td>Annually from age 13 or sexual debut</td><td>Anogenital SCC surveillance</td></tr>
        <tr><td>Endocrine assessment (thyroid, growth, hormones)</td><td>Annually</td><td>Detect endocrine complications</td></tr>
        <tr><td>Audiology</td><td>As indicated</td><td>Hearing loss (especially post-HSCT with drug toxicity)</td></tr>
        <tr><td>HPV vaccination</td><td>Per schedule (ideally before HSCT)</td><td>Reduce SCC risk</td></tr>
      </tbody>
    </table>
    <p style="font-size:14px; color:var(--text-light); margin-top:12px;">Full guidelines: <a href="https://www.fanconi.org/medical-professionals/guidelines/" target="_blank" style="color:var(--primary-light);">FARF Clinical Practice Guidelines</a></p>
  </section>

  <section class="section fade-in" id="psychological">
    <div class="section-header">
      <span class="sec-icon">üß†</span>
      <div><h2>Mental Health & Family Support</h2>
      <p>Living with uncertainty: supporting patients and families</p></div>
    </div>
    <div class="info-box warning">
      <h4>FA has profound psychological impact on the entire family</h4>
      <p>FA is diagnosed in childhood, involves life-threatening complications, requires intense medical surveillance, and may affect siblings (recurrence risk 25%). Parental guilt, anticipatory grief, and caregiver burnout are common. Siblings may feel neglected or survivor's guilt if unaffected. Early psychological support for the whole family improves outcomes.</p>
    </div>
    <div class="cards-grid">
      <div class="card green">
        <div class="card-icon">üë®‚Äçüë©‚Äçüëß</div>
        <h3>Family-Centered Care</h3>
        <p>Best-practice FA centers provide psychosocial support as a standard part of care. This includes: genetic counseling for parents and adult siblings, psychological support during transplant, school re-integration planning after HSCT, and transitional care planning for adolescents moving to adult medicine.</p>
      </div>
      <div class="card orange">
        <div class="card-icon">üë•</div>
        <h3>Peer & Community Support</h3>
        <p>FARF provides family camps and peer connection programs. Connecting with other FA families reduces isolation and provides practical wisdom on navigating complex medical systems. Online communities offer real-time support globally.</p>
      </div>
    </div>
  </section>

  <section class="section fade-in" id="resources">
    <div class="section-header">
      <span class="sec-icon">üåê</span>
      <div><h2>International Resources</h2>
      <p>Patient organizations, specialist centers, and research networks</p></div>
    </div>
    <div class="cards-grid">
      <div class="card green">
        <div class="card-icon">üá∫üá∏</div>
        <h3>Fanconi Anemia Research Fund (FARF)</h3>
        <p>The leading international organization funding FA research and supporting families. Provides clinical practice guidelines, family camps, specialist center directory, and the FA scientific symposium. Based in the US but serves families worldwide.</p>
        <a href="https://www.fanconi.org/" target="_blank" class="link-btn green" style="margin-top:12px;">fanconi.org</a>
      </div>
      <div class="card orange">
        <div class="card-icon">üá™üá∫</div>
        <h3>European Reference Network ‚Äî EuroBloodNet</h3>
        <p>EU network connecting rare blood disorder specialists across Europe. FA patients in Europe can access ERN expertise for diagnosis and treatment. The ERN GUARD-HEART also covers hereditary cardiac conditions associated with FA.</p>
        <a href="https://eurobloodnet.eu/" target="_blank" class="link-btn orange" style="margin-top:12px;">eurobloodnet.eu</a>
      </div>
      <div class="card blue">
        <div class="card-icon">üè•</div>
        <h3>Comprehensive FA Centers</h3>
        <p>Specialized FA centers with full multidisciplinary expertise: <strong>Rockefeller University (NY)</strong>, <strong>Cincinnati Children's</strong>, <strong>University of Minnesota</strong>, <strong>Hospital Vall d'Hebron (Barcelona)</strong>, <strong>Hannover Medical School</strong>. These centers manage complex cases and conduct leading research.</p>
      </div>
      <div class="card">
        <div class="card-icon">üî¨</div>
        <h3>FA Research Consortium</h3>
        <p>International research network coordinating FA science and clinical trials. Patient registries are maintained by FARF and the International Fanconi Anemia Registry (IFAR) at Rockefeller University ‚Äî participation contributes to research.</p>
        <a href="https://www.fanconi.org/research/fanconi-anemia-research-consortium/" target="_blank" class="link-btn" style="margin-top:12px;">FA Research Consortium</a>
      </div>
    </div>
    <div style="margin-top:30px;">
      <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fanconi+anemia&filter=dates.2023-2026&sort=date" target="_blank" class="link-btn">Recent FA Research ‚Äî PubMed</a>
      <a href="https://clinicaltrials.gov/search?cond=fanconi+anemia&recrs=a" target="_blank" class="link-btn green">Open Trials</a>
      <a href="https://www.orpha.net/en/disease/detail/84" target="_blank" class="link-btn orange">Orphanet ‚Äî FA</a>
    </div>
  </section>

  <div class="carepedia-cta">
    <h3>More CarePedia Portals</h3>
    <p>Evidence-based information portals for complex and rare conditions worldwide.</p>
    <a href="/en/" class="cta-btn">Browse All Portals ‚Üí</a>
  </div>

<footer class="footer">
  <p>&copy; 2025 CarePedia &mdash; International Patient Information Hub</p>
  <p style="margin-top:8px; opacity:0.7; font-size:13px;">This information is for educational purposes only. Always consult your healthcare team.</p>
</footer>
<button class="scroll-top" onclick="window.scrollTo({top:0,behavior:'smooth'})">&#8679;</button>

<script>
  // Scroll progress
  window.addEventListener('scroll', () => {
    const el = document.querySelector('.scroll-progress .bar');
    if (el) {
      const pct = (window.scrollY / (document.body.scrollHeight - window.innerHeight)) * 100;
      el.style.width = Math.min(pct, 100) + '%';
    }
    const st = document.querySelector('.scroll-top');
    if (st) st.classList.toggle('visible', window.scrollY > 400);
    document.querySelectorAll('.sidebar nav a').forEach(a => {
      const sec = document.querySelector(a.getAttribute('href'));
      if (sec) {
        const r = sec.getBoundingClientRect();
        a.classList.toggle('active', r.top <= 100 && r.bottom >= 100);
      }
    });
  });
  function toggleMenu() {
    document.querySelector('.sidebar').classList.toggle('open');
    document.querySelector('.menu-toggle').classList.toggle('open');
    document.querySelector('.sidebar-overlay').classList.toggle('active');
  }
  function closeMenu() {
    document.querySelector('.sidebar').classList.remove('open');
    document.querySelector('.menu-toggle').classList.remove('open');
    document.querySelector('.sidebar-overlay').classList.remove('active');
  }
  function navigate(id) { closeMenu(); document.getElementById(id)?.scrollIntoView({behavior:'smooth'}); }
  function toggleAccordion(h) {
    const body = h.nextElementSibling;
    const isOpen = h.classList.contains('open');
    document.querySelectorAll('.accordion-header.open').forEach(oh => {
      oh.classList.remove('open'); oh.nextElementSibling.style.maxHeight = '0';
    });
    if (!isOpen) { h.classList.add('open'); body.style.maxHeight = body.scrollHeight + 'px'; }
  }
  function switchTab(btn, contentId) {
    const parent = btn.closest('.tab-section');
    parent.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
    parent.querySelectorAll('.tab-content').forEach(c => c.classList.remove('active'));
    btn.classList.add('active');
    parent.querySelector('#' + contentId)?.classList.add('active');
  }
  function searchPortal(q) {
    const term = q.toLowerCase();
    document.querySelectorAll('.section').forEach(s => {
      s.style.display = (!term || s.textContent.toLowerCase().includes(term)) ? '' : 'none';
    });
  }
  const obs = new IntersectionObserver((entries) => {
    entries.forEach(e => { if (e.isIntersecting) e.target.classList.add('visible'); });
  }, { threshold: 0.1 });
  document.addEventListener('DOMContentLoaded', () => {
    document.querySelectorAll('.fade-in').forEach(el => obs.observe(el));
  });
</script>

</main>
</body>
</html>
